Soleno Therapeutics, Inc. Common Stock
XNAS:SLNO
50.42
$51.50 - 20.00
$42.00 - 1.00
$49.63
$51.11
$49.63
$49.55
90.32
41.5
880228
1653463.3
49300623.84
Chart
TendieTensor AI Analysis
Company
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Fundamentals
133
-27.390000
5.475590
0.47
100
BBG0024L5B86
BBG0024L5B95
53.15M
53.71M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News